Claes Lindblad
Director of Finance/CFO chez MODUS THERAPEUTICS HOLDING AB
Profil
Claes Lindblad is currently the Chief Financial Officer at Modus Therapeutics Holding AB since 2021.
Prior to this, he worked as the Chief Financial Officer & Secretary at OssDsign AB from 2016 to 2020.
He also worked as the Manager-National Sales at Nycomed AB from 2009 to 2012 and as a Director at ConvaTec (Sweden) AB.
Mr. Lindblad has a graduate degree from Karlstad University and an MBA from Edinburgh Business School.
Postes actifs de Claes Lindblad
| Sociétés | Poste | Début |
|---|---|---|
| MODUS THERAPEUTICS HOLDING AB | Director of Finance/CFO | 15/03/2021 |
Anciens postes connus de Claes Lindblad
| Sociétés | Poste | Fin |
|---|---|---|
| OSSDSIGN AB | Director of Finance/CFO | 01/01/2020 |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Sales & Marketing | 01/07/2012 |
| ConvaTec (Sweden) AB | Director/Board Member | - |
Formation de Claes Lindblad
| Karlstad University | Graduate Degree |
| Edinburgh Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OSSDSIGN AB | Health Technology |
| MODUS THERAPEUTICS HOLDING AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Health Technology |
| ConvaTec (Sweden) AB |
